Home Biotech UCB Forms Research Unit within Kings College London

UCB Forms Research Unit within Kings College London


Anna Smith of Pharma Times reports that Belgium-based biopharma UCB has expanded its global satellite research site strategy by signing a three-year research and development agreement with King’s College London. The two will collaborate at the Guy’s Campus, where King’s is developing a biotech hub—to optimize the collective expertise in effectively translating basic research and clinical insights to new treatments for patients with unmet needs. UCB has already announced it will invest up to £1 billion over five years to renew and enhance its major R&D hub in the UK—UCB seeks to leverage to major R&D hubs—one in Belgium and one in the UK.


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.